Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out whether mitral regurgitation (or a leaky heart valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve after administration of ranolazine.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT01979965
Study type Interventional
Source University Cardiology
Contact
Status Enrolling by invitation
Phase Phase 4
Start date November 2013
Completion date September 2014

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04396379 - Epicardial Mitral Touch System for Mitral Insufficiency N/A
Not yet recruiting NCT04106648 - Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
Recruiting NCT05469165 - Serotonin Receptor Blockers in Ischemic Mitral Regurgitation Phase 2
Suspended NCT04023058 - Stress Echo for Ischemic Mitral Valve Surgery N/A